Literature DB >> 15336236

Pharmacotherapy for cataplexy.

William C Houghton1, Thomas E Scammell, Michael Thorpy.   

Abstract

A variety of medications representing several major drug classes improve cataplexy in patients with narcolepsy. These include aminergic reuptake inhibitors such as venlafaxine and clomipramine as well as sodium oxybate. This review is intended to familiarize readers with the safety and efficacy of these medications, thus enabling clinicians to optimize their management of cataplexy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336236     DOI: 10.1016/j.smrv.2004.01.004

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  8 in total

Review 1.  Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.

Authors:  Michael J Thorpy
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Cataplexy and Its Mimics: Clinical Recognition and Management.

Authors:  Sigrid Pillen; Fabio Pizza; Karlien Dhondt; Thomas E Scammell; Sebastiaan Overeem
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

Review 3.  Treatment of narcolepsy and other hypersomnias of central origin.

Authors:  Merrill S Wise; Donna L Arand; R Robert Auger; Stephen N Brooks; Nathaniel F Watson
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

4.  Narcolepsy: a review.

Authors:  Gbolagade Sunmaila Akintomide; Hugh Rickards
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-08       Impact factor: 2.570

Review 5.  Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.

Authors:  Sheng-Min Wang; Changsu Han; Won-Myoung Bahk; Soo-Jung Lee; Ashwin A Patkar; Prakash S Masand; Chi-Un Pae
Journal:  Chonnam Med J       Date:  2018-05-25

6.  A Simple Sample Preparation with HPLC-UV Method for Estimation of Clomipramine from Plasma.

Authors:  Sayed Abolfazl Mostafavi; Reza Tahvilian; Masoumeh Dehghani Poudeh; Zeinab Rafeepour
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

Review 7.  The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression.

Authors:  Yi-Qun Wang; Rui Li; Meng-Qi Zhang; Ze Zhang; Wei-Min Qu; Zhi-Li Huang
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

8.  Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy.

Authors:  Ali Seifinejad; Sha Li; Marie-Laure Possovre; Anne Vassalli; Mehdi Tafti
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.